Philipp Rothe

2.4k total citations · 1 hit paper
17 papers, 1.4k citations indexed

About

Philipp Rothe is a scholar working on Psychiatry and Mental health, Philosophy and Clinical Psychology. According to data from OpenAlex, Philipp Rothe has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 7 papers in Philosophy and 6 papers in Clinical Psychology. Recurrent topics in Philipp Rothe's work include Schizophrenia research and treatment (16 papers), Mental Health and Psychiatry (7 papers) and Obsessive-Compulsive Spectrum Disorders (5 papers). Philipp Rothe is often cited by papers focused on Schizophrenia research and treatment (16 papers), Mental Health and Psychiatry (7 papers) and Obsessive-Compulsive Spectrum Disorders (5 papers). Philipp Rothe collaborates with scholars based in Germany, United States and United Kingdom. Philipp Rothe's co-authors include Stefan Leucht, John M. Davis, Johannes Schneider‐Thoma, Maximilian Huhn, Marc Krause, Myrto Samara, Thomas J. Arndt, Natalie Peter, Andrea Cipriani and Adriani Nikolakopoulou and has published in prestigious journals such as The Lancet, Cochrane Database of Systematic Reviews and Schizophrenia Research.

In The Last Decade

Philipp Rothe

16 papers receiving 1.4k citations

Hit Papers

Comparative efficacy and tolerability of 32 oral antipsyc... 2019 2026 2021 2023 2019 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Rothe Germany 10 1.1k 242 234 193 175 17 1.4k
Spyridon Siafis Germany 22 985 0.9× 250 1.0× 258 1.1× 184 1.0× 148 0.8× 79 1.6k
Natalie Peter Germany 8 808 0.8× 189 0.8× 161 0.7× 127 0.7× 134 0.8× 11 1.2k
Magdolna Tardy Germany 10 1.0k 1.0× 205 0.8× 384 1.6× 277 1.4× 111 0.6× 13 1.4k
J.M. Olivares Spain 25 1.1k 1.0× 225 0.9× 426 1.8× 262 1.4× 325 1.9× 96 2.0k
Franziska Schmid Germany 11 1.4k 1.3× 255 1.1× 271 1.2× 234 1.2× 165 0.9× 23 1.8k
Thomas J. Arndt United States 8 760 0.7× 171 0.7× 147 0.6× 117 0.6× 133 0.8× 8 1.1k
Heike Hunger Germany 13 1.5k 1.4× 273 1.1× 282 1.2× 245 1.3× 170 1.0× 14 1.9k
Yuya Mizuno Japan 18 911 0.9× 192 0.8× 353 1.5× 92 0.5× 183 1.0× 35 1.7k
Luchezar Hranov Israel 9 1.1k 1.0× 179 0.7× 319 1.4× 275 1.4× 120 0.7× 17 1.3k
Anna Eramo United States 20 841 0.8× 185 0.8× 225 1.0× 231 1.2× 110 0.6× 58 1.2k

Countries citing papers authored by Philipp Rothe

Since Specialization
Citations

This map shows the geographic impact of Philipp Rothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Rothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Rothe more than expected).

Fields of papers citing papers by Philipp Rothe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Rothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Rothe. The network helps show where Philipp Rothe may publish in the future.

Co-authorship network of co-authors of Philipp Rothe

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Rothe. A scholar is included among the top collaborators of Philipp Rothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Rothe. Philipp Rothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Samara, Myrto, Bartosz Helfer, Claudia Leucht, et al.. (2025). Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia. Cochrane Database of Systematic Reviews. 2025(4). CD011885–CD011885.
2.
Vasić, Nenad, Verena Klein, Michael Fritz, et al.. (2022). Gender Differences in the Psychopharmacological Treatment of Forensic In-Patients With Schizophrenia. Frontiers in Psychiatry. 13. 907123–907123. 2 indexed citations
3.
Huhn, Maximilian, Claudia Leucht, Philipp Rothe, et al.. (2020). Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial. European Archives of Psychiatry and Clinical Neuroscience. 271(2). 293–302. 27 indexed citations
4.
Huhn, Maximilian, Adriani Nikolakopoulou, Johannes Schneider‐Thoma, et al.. (2020). Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi-Episode Schizophrenia: A Systematic Review and Network Meta-Analysis. FOCUS The Journal of Lifelong Learning in Psychiatry. 18(4). 443–455. 42 indexed citations
5.
Franke, Irina, et al.. (2020). Comparison of outcome in men and women after treatment in psychiatric security hospitals in Germany. Behavioral Sciences & the Law. 38(5). 456–470. 7 indexed citations
6.
Huhn, Maximilian, Adriani Nikolakopoulou, Johannes Schneider‐Thoma, et al.. (2019). Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. The Lancet. 394(10202). 939–951. 963 indexed citations breakdown →
7.
Krause, Marc, Maximilian Huhn, Johannes Schneider‐Thoma, et al.. (2018). Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis. European Neuropsychopharmacology. 28(12). 1360–1370. 28 indexed citations
8.
Samara, Myrto, Elisabeth Klupp, Bartosz Helfer, et al.. (2018). Increasing antipsychotic dose for non response in schizophrenia. Cochrane Database of Systematic Reviews. 2018(5). CD011883–CD011883. 20 indexed citations
9.
Samara, Myrto, Elisabeth Klupp, Bartosz Helfer, et al.. (2018). Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia. Cochrane Database of Systematic Reviews. 2018(5). CD011884–CD011884. 9 indexed citations
10.
Zhu, Yikang, Marc Krause, Maximilian Huhn, et al.. (2017). Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses. The Lancet Psychiatry. 4(9). 694–705. 88 indexed citations
11.
Zhu, Yikang, Chunbo Li, Maximilian Huhn, et al.. (2017). How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis. European Neuropsychopharmacology. 27(9). 835–844. 92 indexed citations
12.
Rothe, Philipp, Stephan Heres, & Stefan Leucht. (2017). Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method. Schizophrenia Research. 193. 23–28. 33 indexed citations
13.
Samara, Myrto, Bartosz Helfer, Philipp Rothe, & Stefan Leucht. (2015). Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia. Cochrane Database of Systematic Reviews. 2 indexed citations
14.
Helfer, Bartosz, Stefan Leucht, Philipp Rothe, & Myrto Samara. (2015). Increasing antipsychotic dose for non response in schizophrenia. Cochrane Database of Systematic Reviews. 2 indexed citations
15.
Helfer, Bartosz, Philipp Rothe, Stefan Leucht, & Myrto Samara. (2015). Switching antipsychotic for non response in schizophrenia. Cochrane Database of Systematic Reviews. 1 indexed citations
16.
Leucht, Stefan, Philipp Rothe, John M. Davis, & Rolf R. Engel. (2013). Equipercentile linking of the BPRS and the PANSS. European Neuropsychopharmacology. 23(8). 956–959. 98 indexed citations
17.
Timms, Peter, et al.. (1985). Severe hypocalcemia and increased creatine kinase activity.. BMJ. 291(6500). 937–938. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026